UNAIDS Executive Director Winnie Byanyima Calls For “People’s” COVID Vaccine – Need To Get Core Public Health Programmes Back On Track 26/11/2020 J Hacker & Paul Adepoju Far greater investment in global pandemic response is required to ensure that core public health initiatives, like AIDS prevention and treatment aren’t thrown off course by future pandemics, while roll-out of a cheap and accessible “People’s Vaccine” would help get other core public health programmes quickly back on track, UNAIDS has said. In a message […] Continue reading -> Rewriting the Script For Cervical Cancer – WHO Launches New Elimination Strategy 17/11/2020 Svĕt Lustig Vijay In the early 2000’s, when Kenyan doctor Sally Agallo Kwenda was diagnosed with cervical cancer, it was a big shock given she was not experiencing any pain or symptoms. A bigger shock, however, was her husband’s decision to walk out on her. He claimed that he could not live with a woman who could not […] Continue reading -> African Clinics On The Frontline Of The Fight Against Cervical Cancer 05/11/2020 Pip Cook/Geneva Solutions Health experts will meet at the upcoming Geneva Health Forum to discuss the World Health Organisation’s (WHO) new roadmap for the elimination of cervical cancer. Hopes are high for funding to expand services in countries where they are needed the most. At Newlands Clinic in Harare, Zimbabwe, the waiting room is always busy with women […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> The Pandemic Will End – But Tuberculosis, Tobacco and Air Pollution Will Continue To Steal Our Global Breath – Unless We Reimagine The Future 20/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading -> Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding 13/08/2020 Grace Ren Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
Rewriting the Script For Cervical Cancer – WHO Launches New Elimination Strategy 17/11/2020 Svĕt Lustig Vijay In the early 2000’s, when Kenyan doctor Sally Agallo Kwenda was diagnosed with cervical cancer, it was a big shock given she was not experiencing any pain or symptoms. A bigger shock, however, was her husband’s decision to walk out on her. He claimed that he could not live with a woman who could not […] Continue reading -> African Clinics On The Frontline Of The Fight Against Cervical Cancer 05/11/2020 Pip Cook/Geneva Solutions Health experts will meet at the upcoming Geneva Health Forum to discuss the World Health Organisation’s (WHO) new roadmap for the elimination of cervical cancer. Hopes are high for funding to expand services in countries where they are needed the most. At Newlands Clinic in Harare, Zimbabwe, the waiting room is always busy with women […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> The Pandemic Will End – But Tuberculosis, Tobacco and Air Pollution Will Continue To Steal Our Global Breath – Unless We Reimagine The Future 20/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading -> Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding 13/08/2020 Grace Ren Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
African Clinics On The Frontline Of The Fight Against Cervical Cancer 05/11/2020 Pip Cook/Geneva Solutions Health experts will meet at the upcoming Geneva Health Forum to discuss the World Health Organisation’s (WHO) new roadmap for the elimination of cervical cancer. Hopes are high for funding to expand services in countries where they are needed the most. At Newlands Clinic in Harare, Zimbabwe, the waiting room is always busy with women […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> The Pandemic Will End – But Tuberculosis, Tobacco and Air Pollution Will Continue To Steal Our Global Breath – Unless We Reimagine The Future 20/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading -> Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding 13/08/2020 Grace Ren Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> The Pandemic Will End – But Tuberculosis, Tobacco and Air Pollution Will Continue To Steal Our Global Breath – Unless We Reimagine The Future 20/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading -> Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding 13/08/2020 Grace Ren Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
The Pandemic Will End – But Tuberculosis, Tobacco and Air Pollution Will Continue To Steal Our Global Breath – Unless We Reimagine The Future 20/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading -> Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding 13/08/2020 Grace Ren Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
Most Sexual & Reproductive Health Research Financing Comes From 3 Major Donors – And COVID-19 Could Further Shrink Funding 13/08/2020 Grace Ren Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Lockdowns Leave Vaccine Campaigns On Hold; More Africans Could Die From Other Infectious Diseases, Warns GAVI, The Vaccine Alliance 30/04/2020 Svĕt Lustig Vijay Routine vaccine campaigns, suspended worldwide in the wake of COVID-19 lockdowns, must be resumed immediately or else some countries could face a big surge in deaths from other preventable diseases, said Seth Berkley, CEO of Gavi, The Vaccine Alliance. Speaking at a press briefing Thursday, Berkley warned that routine immunizations for other infectious diseases such […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts
Global Fund Announces Record-High Funding Allocations To Countries To Fight AIDS, TB and Malaria 18/12/2019 Editorial team After collecting a windfall of nearly US$14 billion in donor commitments in October, the Global Fund to Fight AIDS, TB and Malaria, on Wednesday published its blueprint to distribute most of the money to over 100 low- and middle-income countries worldwide, saying that allocations will increase by 23% over the next three years. Nigeria, Mozambique […] Continue reading -> Posts navigation Older postsNewer posts